Overall rank by patents
#340
Across all tracked assignees
USPTO PatentsView assignee record - 1,265 granted patents across 51 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
Edwards holds 1,265 US patents across 51 technology areas, rank #340 of 50,000 tracked assignees.
Edwards Lifesciences Corporation has been granted 1,265 US utility patents between 2015 and 2025, placing Edwards Lifesciences Corporation at rank #340 across all assignees tracked by PlainPatent. This portfolio spans 51 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Edwards Lifesciences Corporation is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Edwards sits between Google Technology Holdings Llc (1,294 patents, rank #336) and Merck Sharp & Dohme Llc (1,248 patents, rank #344) - the closest US assignees by grant volume. The composite Innovation Score of 67.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 864 grants, compared with 401 in the 2015–2019 window, a +115% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Edwards Lifesciences Corporation's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 51 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Edwards Lifesciences Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GOOGLE TECHNOLOGY HOLDINGS LLC
1,294 patents
MAKITA CORPORATION
1,292 patents
NIPPON STEEL CORPORATION
1,289 patents
SZ DJI TECHNOLOGY CO., LTD.
1,268 patents
EDWARDS LIFESCIENCES CORPORATION
1,265 patents
The Trustees of the University of Pennsylvania
1,264 patents
Terumo Kabushiki Kaisha
1,250 patents
Empire Technology Development LLC
1,248 patents
Merck Sharp & Dohme LLC
1,248 patents
What this shows Edwards holds 1,265 patents at rank #340, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #340 in granted patent volume.
Other assignees with the most granted patents in Edwards's primary technology class.
Edwards's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
67 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 49 | 3.9% |
| 2016 | 66 | 5.2% |
| 2017 | 61 | 4.8% |
| 2018 | 91 | 7.2% |
| 2019 | 134 | 10.6% |
| 2020 | 153 | 12.1% |
| 2021 | 157 | 12.4% |
| 2022 | 112 | 8.9% |
| 2023 | 138 | 10.9% |
| 2024 | 172 | 13.6% |
| 2025 | 132 | 10.4% |
Top 15 of 51 technology areas
Overall rank by patents
#340
Across all tracked assignees
67.2 out of 100
How to use this portfolio
Edwards's 1,265 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.